eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
5/2006
vol. 23
 
Share:
Send email
Share:
abstract:

Case report
The symptoms of angioedema and urticaria in the course of endocrinopathy

Andrzej Bożek
,
Jolanta Krajewska
,
Ewa Hadas
,
Barbara Filipowska
,
Jerzy Jarząb

Post Dermatol Alergol 2006; XXIII, 5: 244–247
Online publish date: 2006/11/03
View full text Get citation
 
The study presents four cases of recurrent angioneurotic oedema and/or chronic urticaria with the concomitant following endocrine disorders: hyperthyroidism, adrenal adenoma and carcinoid. In two patients thyrotoxicosis was associated with urticaria which disappeared completely after antithyroid drug therapy. This phenomenon can be explained by the influence of antithyroid antibodies and thyroid hormones which may increase mastocyte degranulation. In another patient with adrenal adenoma, a serious angioneurotic oedema resistant to routine treatment was observed. Surgical removal of the adrenal tumour caused complete regression of all symptoms. The next patient with hormonal active intestinal carcinoid accompanied by chronic urticaria was stated. All dermatological signs receded after chemotheraphy and 131I MIBG therapy. In these two endocrinopathies biogenic amines and peptide hormones may cause urticaria.
keywords:

urticaria, carcinoid, hyperthyroidism
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Choroby alergiczne w praktyce lekarza rodzinnego • Alergologia – kompendium
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.